88 related articles for article (PubMed ID: 14701718)
1. Tauroursodeoxycholate inhibits human cholangiocarcinoma growth via Ca2+-, PKC-, and MAPK-dependent pathways.
Alpini G; Kanno N; Phinizy JL; Glaser S; Francis H; Taffetani S; LeSage G
Am J Physiol Gastrointest Liver Physiol; 2004 Jun; 286(6):G973-82. PubMed ID: 14701718
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of alpha2-adrenergic receptor inhibits cholangiocarcinoma growth through modulation of Raf-1 and B-Raf activities.
Kanno N; Lesage G; Phinizy JL; Glaser S; Francis H; Alpini G
Hepatology; 2002 Jun; 35(6):1329-40. PubMed ID: 12029618
[TBL] [Abstract][Full Text] [Related]
3. Involvement of p38 mitogen-activated protein kinase signaling in transformed growth of a cholangiocarcinoma cell line.
Tadlock L; Patel T
Hepatology; 2001 Jan; 33(1):43-51. PubMed ID: 11124819
[TBL] [Abstract][Full Text] [Related]
4. [Studies on cell signaling immunomodulated murine peritoneal suppressor macrophages: LPS and PMA mediate the activation of RAF-1, MAPK p44 and MAPK p42 and p38 MAPK].
Chang ZL; Lin MQ; Wang MZ; Yao Z
Shi Yan Sheng Wu Xue Bao; 1997 Mar; 30(1):73-81. PubMed ID: 10684111
[TBL] [Abstract][Full Text] [Related]
5. Gastrin inhibits cholangiocarcinoma growth through increased apoptosis by activation of Ca2+-dependent protein kinase C-alpha.
Kanno N; Glaser S; Chowdhury U; Phinizy JL; Baiocchi L; Francis H; LeSage G; Alpini G
J Hepatol; 2001 Feb; 34(2):284-91. PubMed ID: 11281558
[TBL] [Abstract][Full Text] [Related]
6. Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha.
Alpini G; Baiocchi L; Glaser S; Ueno Y; Marzioni M; Francis H; Phinizy JL; Angelico M; Lesage G
Hepatology; 2002 May; 35(5):1041-52. PubMed ID: 11981754
[TBL] [Abstract][Full Text] [Related]
7. Endothelial exposure to hypoxia induces Egr-1 expression involving PKCalpha-mediated Ras/Raf-1/ERK1/2 pathway.
Lo LW; Cheng JJ; Chiu JJ; Wung BS; Liu YC; Wang DL
J Cell Physiol; 2001 Sep; 188(3):304-12. PubMed ID: 11473356
[TBL] [Abstract][Full Text] [Related]
8. Celecoxib-induced apoptosis in rat cholangiocarcinoma cells mediated by Akt inactivation and Bax translocation.
Zhang Z; Lai GH; Sirica AE
Hepatology; 2004 Apr; 39(4):1028-37. PubMed ID: 15057907
[TBL] [Abstract][Full Text] [Related]
9. Activation of protein kinase Calpha couples cell volume to membrane Cl- permeability in HTC hepatoma and Mz-ChA-1 cholangiocarcinoma cells.
Roman RM; Bodily KO; Wang Y; Raymond JR; Fitz JG
Hepatology; 1998 Oct; 28(4):1073-80. PubMed ID: 9755245
[TBL] [Abstract][Full Text] [Related]
10. Akt expression may predict favorable prognosis in cholangiocarcinoma.
Javle MM; Yu J; Khoury T; Chadha KS; Iyer RV; Foster J; Kuvshinoff BW; Gibbs JF; Geradts J; Black JD; Brattain MG
J Gastroenterol Hepatol; 2006 Nov; 21(11):1744-51. PubMed ID: 16984600
[TBL] [Abstract][Full Text] [Related]
11. Translational regulation by p38 mitogen-activated protein kinase signaling during human cholangiocarcinoma growth.
Yamagiwa Y; Marienfeld C; Tadlock L; Patel T
Hepatology; 2003 Jul; 38(1):158-66. PubMed ID: 12829998
[TBL] [Abstract][Full Text] [Related]
12. Albumin-stimulated DNA synthesis is mediated by Ca2+/PKC as well as EGF receptor-dependent p44/42 MAPK and NF-kappaB signal pathways in renal proximal tubule cells.
Lee YJ; Han HJ
Am J Physiol Renal Physiol; 2008 Mar; 294(3):F534-41. PubMed ID: 18160626
[TBL] [Abstract][Full Text] [Related]
13. H3 histamine receptor-mediated activation of protein kinase Calpha inhibits the growth of cholangiocarcinoma in vitro and in vivo.
Francis H; Onori P; Gaudio E; Franchitto A; DeMorrow S; Venter J; Kopriva S; Carpino G; Mancinelli R; White M; Meng F; Vetuschi A; Sferra R; Alpini G
Mol Cancer Res; 2009 Oct; 7(10):1704-13. PubMed ID: 19825989
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress reduces Na+/H+ exchange (NHE) activity in a biliary epithelial cancer cell line (Mz-Cha-1).
Elsing C; Voss A; Herrmann T; Kaiser I; Huebner CA; Schlenker T
Anticancer Res; 2011 Feb; 31(2):459-65. PubMed ID: 21378324
[TBL] [Abstract][Full Text] [Related]
15. Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways.
Schoemaker MH; Conde de la Rosa L; Buist-Homan M; Vrenken TE; Havinga R; Poelstra K; Haisma HJ; Jansen PL; Moshage H
Hepatology; 2004 Jun; 39(6):1563-73. PubMed ID: 15185297
[TBL] [Abstract][Full Text] [Related]
16. Calcium-sensing receptor stimulates PTHrP release by pathways dependent on PKC, p38 MAPK, JNK, and ERK1/2 in H-500 cells.
Tfelt-Hansen J; MacLeod RJ; Chattopadhyay N; Yano S; Quinn S; Ren X; Terwilliger EF; Schwarz P; Brown EM
Am J Physiol Endocrinol Metab; 2003 Aug; 285(2):E329-37. PubMed ID: 12700162
[TBL] [Abstract][Full Text] [Related]
17. Bombesin and neuromedin B stimulate the activation of p42(mapk) and p74(raf-1) via a protein kinase C-independent pathway in Rat-1 cells.
Charlesworth A; Rozengurt E
Oncogene; 1997 May; 14(19):2323-9. PubMed ID: 9178908
[TBL] [Abstract][Full Text] [Related]
18. Activation of MAP kinase by muscarinic cholinergic receptors induces cell proliferation and protein synthesis in human breast cancer cells.
Jiménez E; Montiel M
J Cell Physiol; 2005 Aug; 204(2):678-86. PubMed ID: 15744749
[TBL] [Abstract][Full Text] [Related]
19. Dopamine regulates cell cycle regulatory proteins via cAMP, Ca(2+)/PKC, MAPKs, and NF-kappaB in mouse embryonic stem cells.
Lee MY; Heo JS; Han HJ
J Cell Physiol; 2006 Aug; 208(2):399-406. PubMed ID: 16688761
[TBL] [Abstract][Full Text] [Related]
20. Mitogenic signalling by B2 bradykinin receptor in epithelial breast cells.
Greco S; Muscella A; Elia MG; Romano S; Storelli C; Marsigliante S
J Cell Physiol; 2004 Oct; 201(1):84-96. PubMed ID: 15281091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
